Regulatory Professionals, part of the Clinical Professionals Group will be exhibiting at the TOPRA Symposium conference in Dublin, on the 30th September – 2nd October. Regulatory Professionals was founded by The Clinical Professionals Group in 2013 to provide specialist staffing solutions for clients recruiting within the regulatory affairs sector. As part of The Clinical Professionals
Regulatory Senior AssociateRegulatory ProfessionalsHertfordshire, UK
- FULL TIME
Regulatory Affairs Director – CMCRegulatory ProfessionalsBerkshire, UK
- FULL TIME
Regulatory Affairs Associate ManagerRegulatory ProfessionalsBerkshire, UK
- FULL TIME
Associate Director Regulatory Affairs – CMCRegulatory ProfessionalsBuckinghamshire, UK
- FULL TIME
Regulatory Professionals is one of the fastest growing global integrated regulatory outsourcing providers with a network of 20,000 pharmaceutical professionals globally. Working exclusively within the regulatory functions of Pharmaceutical, Biotechnology, Medical Device, Consumer health / OTC and Diagnostics industries.
Our integrated regulatory affairs recruitment team is there to support partner organisations of all sizes. Ranging for one regulatory consultant, to deliver a specialist project, to outsourcing functional regulatory teams of over 100+, Regulatory Professionals are able to offer global support partnered with expert local knowledge. Our capabilities also offer contract and permanent regulatory staffing services to allow a 360 degree service range for all aspects of regulatory delivery.
Our regulatory recruitment teams approach is tailored to meet the needs of our partners requirements allowing you to shift internal R&D focus to more strategic activities to improve lifecycle performance.
The benefits of Regulatory Professionals integrated teams are measured not just in the savings that could result in multi-mullion dollar cost reductions, but equally in understanding that delays in any part of the regulatory cycle affect the ability to give patients access to transformational products.
Our integrated teams support your product portfolio by giving you flexibility of resource at the peaks and troughs of the product life cycle, while ensuring you maintain control of strategic regulatory departments. This is supported by consistent, measurable and tracked metrics to maximise accountability.
To find out more about each of the regulatory areas we specialise in, take a look at the following regulatory recruitment services:
Our experienced specialist recruitment consultants are available to speak to you confidentially about our outsourcing regulatory affairs services. To find out more information or to discuss any of our regulatory vacancies, please call our specialist regulatory affairs recruitment team.
Contact us today to find out how we can progress your career to the next level
NICE have said in a recent statement that Novartis’ gene therapy Luxturna for a rare, inherited form of blindness should be available for routine NHS use in England and Wales. The one-off treatment, which was previously approvedin Europe last November, has been backed by the cost-effectiveness watchdog for use in children and adults living with vision
Alexion Pharmaceuticals’ eculizumab has been approved by the European Commission for the treatment of neuromyelitis optica spectrum disorder (NMOSD), extending its current marketing authorisation. NMOSD is a rare, devastating, complement-mediated disorder of the central nervous system characterised by relapses, also referred to as attacks. Previously known as Devic’s Disease, NMOSD is often confused with other